CDC recommends Janssen suspension after 6 people out of 6.8 million got rare blood clots
Guam and the CNMI have put the brakes on the administration of Johnson& Johnson's Covid-19 vaccine, following the Center for Disease Control and Prevention's recommendation.
The CDC called for a pause on the J&J vaccine, also known as Janssen, pending review of six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the shot.
"In these cases, a type of blood clot called cerebral venous sinus thrombosis was seen in combination with low levels of blood platelets (thrombocytopenia)," Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.
As of April 12, more than 6.8 million doses of the Janssen vaccine have been administered in the U.S.